These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7798781)

  • 1. Progression of experimental chronic renal failure: does platelet-activating factor play a role?
    Tolins JP
    J Lab Clin Med; 1994 Dec; 124(6):740-1. PubMed ID: 7798781
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progression of renal insufficiency and platelet activating factor (PAF)].
    Camici M
    Minerva Med; 1996 Jun; 87(6):289-98. PubMed ID: 8700358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet activating factor (PAF) and kidney failure progression].
    Camici M; Carpi A; Sagripanti A
    Minerva Med; 1997 Sep; 88(9):329-34. PubMed ID: 9411309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of platelet-activating factor in the mammalian female reproductive tract.
    Tiemann U
    Reprod Domest Anim; 2008 Dec; 43(6):647-55. PubMed ID: 18363604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of gene expression by moxonidine in rats with chronic renal failure.
    Vonend O; Apel T; Amann K; Sellin L; Stegbauer J; Ritz E; Rump LC
    Nephrol Dial Transplant; 2004 Sep; 19(9):2217-22. PubMed ID: 15266031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is mannitol effective against platelet-activating factor (PAF)-induced liver damage in obstructive jaundice?
    Coker A; Coker I; Huseyinov A; Sokmen S; Karademir S
    Hepatogastroenterology; 2001; 48(40):1134-7. PubMed ID: 11490817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lipids in the progression of renal disease in chronic renal failure: evidence from animal studies and pathogenesis.
    Shohat J; Boner G
    Isr J Med Sci; 1993 Apr; 29(4):228-39. PubMed ID: 8491578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor in septic shock.
    Koltai M; Hosford D; Braquet PG
    New Horiz; 1993 Feb; 1(1):87-95. PubMed ID: 7922397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using transgenic mice to analyze the mechanisms of progression of chronic renal failure.
    Terzi F; Burtin M; Friedlander G
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S144-8. PubMed ID: 11065347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor 1 resistance in chronic renal failure.
    Fouque D
    Miner Electrolyte Metab; 1996; 22(1-3):133-7. PubMed ID: 8676805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor contributes to postischemic vasospasm.
    Wang WZ; Guo SZ; Tsai TM; Anderson GL; Miller FN
    J Surg Res; 2000 Apr; 89(2):139-46. PubMed ID: 10729242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenic factors and hypertension in chronic renal failure.
    Campese VM
    J Nephrol; 1997; 10(4):184-7. PubMed ID: 9377724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could platelet activating factor play a role in developmental dyslexia?
    Taylor KE; Richardson AJ; Stein JF
    Prostaglandins Leukot Essent Fatty Acids; 2001 Mar; 64(3):173-80. PubMed ID: 11334553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
    Handa RK; Strandhoy JW
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1486-91. PubMed ID: 8667214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of gamma-aminobutyric acid against chronic renal failure in rats.
    Sasaki S; Yokozawa T; Cho EJ; Oowada S; Kim M
    J Pharm Pharmacol; 2006 Nov; 58(11):1515-25. PubMed ID: 17132215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of endothelin in the progression of the renal disease in an experimental model of chronic kidney failure].
    Orisio S; Zoja C; Remuzzi G
    Ann Ital Med Int; 1993; 8(4):213-7. PubMed ID: 8161475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of platelet activating factor in sensitization formation].
    Tuluevskaia LM; Sviatkina OB; Poriadin GV; Vel'tishchev IuE
    Patol Fiziol Eksp Ter; 1993; (2):7-9. PubMed ID: 8058391
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet-activating factor and cytokine production in the perfused rat liver.
    Denizot Y; Nathan N
    Eur Cytokine Netw; 1994; 5(3):261-2. PubMed ID: 7948762
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactive effects of tumor necrosis factor and platelet-activating factor in the pathogenesis of glomerular injury.
    Camussi G
    Lab Invest; 1994 Apr; 70(4):435-6. PubMed ID: 8176883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.